{"schema":"hottub-news/story/v1","story":"st_b43lfv6ndfghekbccl4a","title":"Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)","title_en":null,"outlets":3,"brief":null,"page":"https://hottub.news/stories/lantheus-announces-cms-grants-transitional-pass-through-status-for-b43lfv6ndf","count":3,"items":[{"id":"n_rzgfbqgpi3hqs264mr5q","seq":907604,"kind":"article","title":"Lantheus Holdings, Inc.: Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY TruVu (piflufolastat F 18)","url":"https://www.finanznachrichten.de/nachrichten-2026-09/69718650-lantheus-holdings-inc-lantheus-announces-cms-grants-transitional-pass-through-status-for-pylarify-truvu-piflufolastat-f-18-399.htm","published":"2026-09-30T12:52:37Z","seen":"2026-09-30T12:52:37Z","lang":"en","country":"DE","source":{"id":"finanznachrichten.de","name":"finanznachrichten.de","domain":"finanznachrichten.de","outlet":{"wikidata":"Q1408247","name":"Finanznachrichten.de","type":"website","designations":["website"]}},"via":"gdelt-gkg-english","topics":["economy","science","politics","health"],"authors":["GlobeNewswire (Europe)"],"story":"st_b43lfv6ndfghekbccl4a","category":"economy-business","category_p":0.38999998569488525,"sentiment":"neutral","tone":-0.20000000298023224,"political":0.10000000149011612},{"id":"n_cplzl5fckyipaap2m3yq","seq":912499,"kind":"article","title":"Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)","url":"https://www.manilatimes.net/2026/09/30/tmt-newswire/globenewswire/lantheus-announces-cms-grants-transitional-pass-through-status-for-pylarify-truvu-piflufolastat-f-18/2436096","published":"2026-09-30T12:41:00Z","seen":"2026-09-30T13:17:34Z","lang":"en","source":{"id":"manilatimes.net","name":"manilatimes.net","domain":"manilatimes.net","outlet":{"wikidata":"Q1573100","name":"The Manila Times","type":"magazine","country":"PH","designations":["organization","periodical"]}},"via":"gdelt-gkg-english","topics":["economy","science","business","health"],"entities":[{"id":"Q269909","name":"Andy Burnham","type":"person"}],"story":"st_b43lfv6ndfghekbccl4a","category":"economy-business","category_p":0.23000000417232513,"sentiment":"neutral","tone":-0.10999999940395355,"political":0.15000000596046448},{"id":"n_b43lfv6ndfghekbccl4a","seq":901302,"kind":"press_release","title":"Lantheus Announces CMS Grants Transitional Pass-Through Status for PYLARIFY® TruVu (piflufolastat F 18)","url":"https://www.globenewswire.com/news-release/2026/09/30/3371873/0/en/lantheus-announces-cms-grants-transitional-pass-through-status-for-pylarify-truvu-piflufolastat-f-18.html","summary":"Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agent Designation, together with a permanent HCPCS code effective October 1, 2026, supports patient access and reimbursement for PYLARIFY TruVu, Lantheus' PSMA PET imaging agent","published":"2026-09-30T12:30:00Z","seen":"2026-09-30T12:37:48Z","lang":"en","source":{"id":"globenewswire-public","name":"GlobeNewswire — public companies","domain":"globenewswire.com","outlet":{"wikidata":"Q5570956","name":"GlobeNewswire","type":"other","country":"US","designations":["business","press release distributor"]}},"via":"globenewswire-public","topics":["business","nasdaq:lnth","us5165441032"],"entities":[{"id":"Q131093","name":"content management system","type":"org"}],"story":"st_b43lfv6ndfghekbccl4a","category":"economy-business","category_p":0.23000000417232513,"sentiment":"neutral","tone":0.30000001192092896,"political":0.15000000596046448}]}